Form 4: Health Catalyst Director Duncan Gallagher Sells 4,500 Shares

Director Duncan Gallagher of Health Catalyst, Inc. sold 4,500 shares of common stock at a price of $6.9298 per share on December 30, 2024.

Summary

• On December 30, 2024, Duncan Gallagher, a director at Health Catalyst, Inc. (HCAT), sold 4,500 shares of the company's common stock.
• The sale was executed at a price of $6.9298 per share.
• Following the transaction, Gallagher directly owns 69,938 shares of Health Catalyst common stock.
• The sale was conducted under a pre-arranged trading plan established on May 26, 2024, in accordance with Rule 10b5-1.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it reports a routine insider sale under a pre-arranged trading plan. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Risks

• Sales by insiders can sometimes be perceived negatively by the market, potentially impacting the stock price.

Industry Context

Insider sales are a common occurrence and are often scrutinized by investors for insights into management's perspective on the company's future prospects. Rule 10b5-1 plans allow insiders to sell shares over a predetermined period, mitigating concerns about trading on non-public information.

Stakeholder Impact

• The sale could have a minor impact on shareholder sentiment, depending on how the market interprets the insider's actions.

Key Dates